Cargando…
Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies
SIMPLE SUMMARY: Tumor-associated antigens (TAAs) are antigens present in tumor cells, but are also expressed in normal cells. However, TAAs are aberrantly expressed by tumor cells, and can elicit multiple specific immune responses. One key feature of TAAs is the presence of post-translational modifi...
Autores principales: | Srivastava, Anurag Kumar, Guadagnin, Giorgia, Cappello, Paola, Novelli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817968/ https://www.ncbi.nlm.nih.gov/pubmed/36612133 http://dx.doi.org/10.3390/cancers15010138 |
Ejemplares similares
-
Quantitative Translation in Immuno‐Oncology Research and Development
por: Bottino, Dean, et al.
Publicado: (2020) -
Advancing translational research for colorectal immuno-oncology
por: Thomas, Elaine M., et al.
Publicado: (2023) -
A self antigen reopens the games in pancreatic cancer
por: Cappello, Paola, et al.
Publicado: (2013) -
Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017) -
Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery
por: Sivakumar, Ramya, et al.
Publicado: (2019)